Kathy A. Aldern

1.5k citations

42 papers · 1.2k indexed · h-index 20

Co-authors: Karl Y. Hostetler James R. Beadle Peter J. Hornsby Sandra E. Harris Earl R. Kern George R. Painter William Wan Caroll B. Hartline
Topics: Cytomegalovirus and herpesvirus research (12 papers)Herpesvirus Infections and Treatments (11 papers)HIV/AIDS drug development and treatment (11 papers)
Cited by: Virology Infectious Diseases Epidemiology
Journals: Proceedings of the National Academy of Sciences The Journal of Clinical Endocrinology & Metabolism Biochemical and Biophysical Research Communications
Partner nations: United States Canada Belgium

In The Last Decade

Kathy A. Aldern

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Kathy A. Aldern

Since Specialization

Citations

This map shows the geographic impact of Kathy A. Aldern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy A. Aldern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy A. Aldern more than expected).

Fields of papers citing papers by Kathy A. Aldern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy A. Aldern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy A. Aldern. The network helps show where Kathy A. Aldern may publish in the future.

Co-authorship network of co-authors of Kathy A. Aldern

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy A. Aldern. A scholar is included among the top collaborators of Kathy A. Aldern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy A. Aldern. Kathy A. Aldern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiproliferative Effects of Octadecyloxyethyl 9-[2-(Phosphonomethoxy)Ethyl]Guanine against Me-180 Human Cervical Cancer Cells in vitro and in vivo 2010 ·Chemotherapy ·Nadejda Valiaeva,(unknown),Kathy A. Aldern,James R. Beadle,Karl Y. Hostetler	5
2	Cidofovir and (S)-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine Are Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When Incorporated into the Template Strand 2007 ·Antimicrobial Agents and Chemotherapy ·Wendy C. Magee,Kathy A. Aldern,Karl Y. Hostetler,David H. Evans	72
3	Evaluation of Hexadecyloxypropyl-9- R -[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections 2007 ·Antimicrobial Agents and Chemotherapy ·George R. Painter,Merrick R. Almond,Lawrence C. Trost,Bernhard Lampert,Johan Neyts,Erik De Clercq,Brent E. Korba,Kathy A. Aldern,James R. Beadle,Karl Y. Hostetler	3
4	Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro 2006 ·Antiviral Research ·Nadejda Valiaeva,James R. Beadle,Kathy A. Aldern,(unknown),Karl Y. Hostetler	28
5	Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice 2006 ·Antiviral Research ·Karl Y. Hostetler,James R. Beadle,(unknown),Kathy A. Aldern,(unknown),Jill Schriewer,Lora Melman,R. Mark L. Buller	24
6	Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism 2003 ·Molecular Pharmacology ·Kathy A. Aldern,(unknown),(unknown),Karl Y. Hostetler	110
7	Ganciclovir Release Rates in Vitreous from Different Formulations of 1- O -Hexadecylpropanediol-3-Phospho-Ganciclovir 2003 ·Journal of Ocular Pharmacology and Therapeutics ·Lingyun Cheng,Karl Y. Hostetler,(unknown),James R. Beadle,(unknown),Michael F. Gardner,Kathy A. Aldern,(unknown),William R. Freeman	5
8	Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney 2003 ·Antiviral Research ·(unknown),(unknown),William Wan,James R. Beadle,Kathy A. Aldern,George R. Painter,Karl Y. Hostetler	146
9	Synthesis and Antiviral Evaluation of 1-O-Hexadecylpropanediol-3-P-acyclovir: Efficacy Against HSV-1 Infection in Mice 2000 ·Nucleosides Nucleotides & Nucleic Acids ·James R. Beadle,Ganesh D. Kini,Kathy A. Aldern,Michael F. Gardner,(unknown),Rachel J. Rybak,Earl R. Kern,Karl Y. Hostetler	14
10	In vitro Anti-HIV-1 Activity of sn -2-Substituted 1-O-Octadecyl- sn -Glycero-3-Phosphonoformate Analogues and Synergy with Zidovudine 2000 ·Antiviral chemistry & chemotherapy ·Karl Y. Hostetler,Jennifer Hammond,Ganesh D. Kini,(unknown),James R. Beadle,Kathy A. Aldern,Ting‐Chao Chou,Douglas D. Richman,John W. Mellors	7
11	EVALUATION OF A NOVEL LIPID PRODRUG FOR INTRAOCULAR DRUG DELIVERY 1997 ·Retina ·İbrahim Taşkintuna,Alay Banker,Marisa Flores-Aguilar,(unknown),Kathy A. Aldern,Karl Y. Hostetler,William R. Freeman	13
12	Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cells 1997 ·Antiviral Research ·Ganesh D. Kini,(unknown),James R. Beadle,Kathy A. Aldern	12
13	Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV 1997 ·Antiviral Research ·Ganesh D. Kini,James R. Beadle,Hong Xie,Kathy A. Aldern,Douglas D. Richman,Karl Y. Hostetler	20
14	Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats 1996 ·Toxicology ·Mark J. Reasor,(unknown),(unknown),(unknown),Sam Kacew,Michael F. Gardner,Kathy A. Aldern,Karl Y. Hostetler	28
15	Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro 1996 ·Antiviral Research ·Karl Y. Hostetler,Ganesh D. Kini,James R. Beadle,Kathy A. Aldern,Michael F. Gardner,Richard Border,Raj Kumar,(unknown),Ch. Sridhar,Carl J. Wheeler,Douglas D. Richman	25
16	[11] Assay of phospholipases C and D in presence of other lipid hydrolases 1991 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Karl Y. Hostetler,Michael F. Gardner,Kathy A. Aldern	10
17	Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo 1991 ·Biochemical Pharmacology ·Karl Y. Hostetler,Jerry Vande Berg,Kathy A. Aldern,(unknown)	12
18	Mode of action of butylated hydroxyanisole (BHA) and other phenols in preventing loss of 11β-hydroxylase activity in cultured bovine adrenocortical cells 1985 ·Biochemical Pharmacology ·Peter J. Hornsby,Kathy A. Aldern,Sandra E. Harris	10
19	Steroidogenic Enzyme Activities in Cultured Human Definitive Zone Adrenocortical Cells: Comparison with Bovine Adrenocortical Cells and Resultant Differences in Adrenal Androgen Synthesis* 1984 ·The Journal of Clinical Endocrinology & Metabolism ·Peter J. Hornsby,Kathy A. Aldern	55
20	Mode of action of sulfoxides in preventing loss of activity of 11β-hydroxylase in cultured bovine adrenocortical cells 1984 ·Chemico-Biological Interactions ·Peter J. Hornsby,Sandra E. Harris,Kathy A. Aldern	11

About Kathy A. Aldern

Kathy A. Aldern is a scholar working on Virology, Ophthalmology and Infectious Diseases, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (12 papers), Herpesvirus Infections and Treatments (11 papers) and HIV/AIDS drug development and treatment (11 papers). The work is most often cited by research in Virology (312 citations), Infectious Diseases (382 citations) and Epidemiology (593 citations). Kathy A. Aldern has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Karl Y. Hostetler, James R. Beadle, Peter J. Hornsby, Sandra E. Harris, Earl R. Kern, George R. Painter, William Wan, Caroll B. Hartline, Emma A. Harden and Natalie Rodríguez. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact